Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$EMED Bio-electrical stimulation is a safe non toxic pain management therapy that activates the body’s innate
ability to heal itself. Therapy provides targeted pain alleviation to specific areas of the body by
modifying its electrical language related to pain, regulating signals and stimulating endogenous opioids
distributed in the nervous systems, particularly in circuits involved in pain modulation, reward,
responses to stress, and autonomic control.
$EMED Electrotherapy seems to be one of the most promising substitute to toxic and addictive painkillers. Since introducing the WellnessPro+ in 2007, ElectroMedical Technologies has been an innovation pioneer at the forefront of the alternative pain relief movement.
$EMED Bio-electrical stimulation is a safe non toxic pain management therapy that activates the body’s innate
ability to heal itself. Therapy provides targeted pain alleviation to specific areas of the body by
modifying its electrical language related to pain, regulating signals and stimulating endogenous opioids
distributed in the nervous systems, particularly in circuits involved in pain modulation, reward,
responses to stress, and autonomic control.
$EMED In 2018, 67,367 drug overdose deaths occurred in the United States, 70% of them involved opioids.
https://electromedtech.com/investors-relations/
$IVDN has a new multi-million dollar sales agreement for patented Insultex, the world's highest performing insulation ...
IVDN Patent Approval News as Multi-Million Dollar Int'l Marketing Agreement for Most Effective Energy Saving Insulation: Innovative Designs (OTCQB: IVDN)
Click here:
https://www.marketwatch.com/press-release/patent-approval-multi-million-dollar-intl-marketing-agreement-for-most-effective-energy-saving-insulation-innovative-designs-otcqb-ivdn-2023-02-01
Here are the reasons to buy into BRBL at .0004 soon.
Top Ten Reasons to Buy BRBL
1 Great new company that is making news
https://www.otcmarkets.com/stock/BRBL/news
2 Real revenues and the revenues are increasing two-fold or more with all new News reports
https://www.otcmarkets.com/stock/BRBL/disclosure
3 Exciting new brands to the market and potential for 42 new taprooms opening nationwide.
NEWS
BrewBilt Brewing Finalizes Contract Negotiations to Move Forward With $130M Revenue Partnership
4 Revenues have increased for 2022 over 2021 and they have just gotten into Albertsons/ Safeway
5 Projected profitable by the 3rd quarter of this year.
https://www.otcmarkets.com/filing/html?id=16222968&guid=Cs4-kWJiMHfPdth
6 low share structure and ready to move up at this price
Outstanding Shares 2,056,023,193
02/21/2023
Restricted 1,184,979,955
02/21/2023
Unrestricted 871,043,238
02/21/2023
Held at DTC 827,601,213
02/21/2023
https://www.otcmarkets.com/stock/BRBL/security
7 years over year revenues increase
https://www.otcmarkets.com/filing/html?id=16222968&guid=Cs4-kWJiMHfPdth
8 Has a sister company to invest in that will be adding revenues on all the new taproom openings.
https://www.otcmarkets.com/stock/BRBL/news/story?e&id=2439201
9 Great marketing by the company with all the beer festivals.
https://brewbiltbrewing.com/events/
10 Excellent looking products and already rated high in the looking beer festivals. Growing a nationwide following soon with 42 new taproom franchises to open.
Brewbilt has a clear Level2 to above .005. BRBL
NEWS
BrewBilt Brewing Finalizes Contract Negotiations to Move Forward With $130M Revenue Partnership
GRASS VALLEY, CA, Feb. 02, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Today BrewBilt Brewing Company (the "Company") (OTCPINK: BRBL), announces that after several months of negotiations, the Company has finalized specific terms and conditions to proceed with a contract that will bring BrewBilt Brewing’s craft beers to premier entertainment venues across the country.
Chairman and CEO Jef Lewis stated, “Our strategic partnership will result in development of BrewBilt-powered craft beer breweries throughout the US, starting in California and Florida. This is a partnership that will bring revenue to our craft beer production, as well as to BrewBilt Manufacturing. There are 40 sites projected that would generate $130M in revenue along with continued revenue in commercial craft beer production.”
BrewBilt Brewing Company has very good ratings on the popular craft beer rating site Untappd.com.
Follow us on Twitter (@BrewBiltBrewing) and Instagram (@BrewBilt_Brewing)
ABOUT BREWBILT BREWING COMPANY: (http://www.brewbiltbrewing.com)
Located in the Sierra Foothills of Northern California, BrewBilt Brewing Company produces its own line of premium craft beers. BrewBilt Brewing grew out of BrewBilt Manufacturing Inc., an iconic company that has been handcrafting custom breweries and fermentation systems since 2014. BrewBilt Brewing's production staff consists of industry veterans who use high quality brewing equipment and ingredients to deliver outstanding craft beer to California and beyond.
FORWARD-LOOKING STATEMENTS: This press release contains forward-looking statements. Forward-looking statements provide current expectations or forecasts of future events and are not guarantees of future performance, nor should they be relied upon as representing management's views as of any subsequent date. The forward-looking statements are based on management's expectations and are subject to a number of risks and uncertainties. Although management believes that the expectations reflected in such forward-looking statements are reasonable, actual results may differ materially from those expressed or implied in such statements. Risks and uncertainties that could cause actual results to differ materially include, without limitation, the Company's ability to effectively execute its business plans; unforeseen construction delays; the Company's need for additional capital; changes in general economic and financial market conditions; changes in the competitive environment; litigation; losses, customer bankruptcy, claims and assessments; and regulatory or legislative requirements affecting the Company's business. Management may elect to update forward-looking statements at some future point; however, it specifically disclaims any obligation to do so.
Contact:
Jef Lewis, CEO
BrewBilt Brewing Company
(530) 802-0036
Info@BrewBiltBrewing.com
Source: BrewBilt Brewing Company
$PVSP While the local Washington market presents compelling opportunities for the acquisition and roll-up of wholesale flower, concentrate, and other related production assets by Zen’s independent cultivators, the regulatory environment in Washington prevents vertical integration into retail assets. That limitation is a significant constraint on growth since Zen’s independent cultivators cannot acquire dispensary assets to internalize retail revenues that are typically about three times wholesale receipts. Stated differently, Artizen could be generating about three times its current revenues, or about $46 to $52 million, if Zen’s existing footprint was in another state. Thus, diversification has been and remains a key strategic focus – both within Washington by expanding Zen’s offerings and exploiting compliant acquisition opportunities, and in valuable emerging cannabis markets by replicating Artizen’s proven formula for success in new U.S. and Canadian geographies.
https://www.barrons.com/articles/pervasip-announces-artizen-spin-off-01673965206?mod=md_stockoverview_news
$GBHL
$PVSP Pervasip previously announced its identification of a series of exciting expansion opportunities, including potential acquisitions involving licensed wholesale and retail operations that would offer Artizen the potential to establish itself as a vertically integrated multi-state operator (“MSO”).
https://www.benzinga.com/markets/cannabis/23/01/30465565/pervasip-announces-artizen-spin-off?utm_campaign=partner_feed&utm_source=MarketWatch&utm_medium=partner_feed&utm_content=site&mod=mw_quote_news
$GBHL
$PVSP While the local Washington market presents compelling opportunities for the acquisition and roll-up of wholesale flower, concentrate, and other related production assets by Zen’s independent cultivators, the regulatory environment in Washington prevents vertical integration into retail assets. That limitation is a significant constraint on growth since Zen’s independent cultivators cannot acquire dispensary assets to internalize retail revenues that are typically about three times wholesale receipts. Stated differently, Artizen could be generating about three times its current revenues, or about $46 to $52 million, if Zen’s existing footprint was in another state. Thus, diversification has been and remains a key strategic focus – both within Washington by expanding Zen’s offerings and exploiting compliant acquisition opportunities, and in valuable emerging cannabis markets by replicating Artizen’s proven formula for success in new U.S. and Canadian geographies.
https://www.barrons.com/articles/pervasip-announces-artizen-spin-off-01673965206?mod=md_stockoverview_news
$GBHL
$PVSP SEATTLE, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Pervasip Corp. (OTCPK: PVSP) (“Pervasip” and the “Company”) today announced that it will spin-off 100% of its wholly-owned subsidiary, Artizen Corporation (“Artizen”), as a separate public company, with an anticipated record date between July 1, 2023, and September 30, 2023. As a result of the spin-off, all Pervasip shareholders of record as of the designated record date shall receive shares in the newly public Artizen in proportion to their ownership in Pervasip. Artizen conducts 100% of Pervasip’s cannabis business segment operations through its Zen Asset Management LLC subsidiary ("Zen”).
https://www.nasdaq.com/press-release/pervasip-announces-artizen-spin-off-2023-01-17
$GBHL
$PVSP Positioning for Expansion
“Spinning out Artizen will allow us to properly capitalize the business to take advantage of multiple expansion opportunities to build on our existing foundation,” said German Burtscher, Chairman and Chief Executive Officer of Pervasip and Artizen.
https://seekingalpha.com/pr/19084459-pervasip-announces-artizen-spin-off
$GBHL
TIA $Aris Mining Red Cloud On-Site Interview at VRIC
Here is the link to Tyron Bretonbach providing an interview to Red Cloud at VRIC 2023
Mining Conference.
$PVSP While the local Washington market presents compelling opportunities for the acquisition and roll-up of wholesale flower, concentrate, and other related production assets by Zen’s independent cultivators, the regulatory environment in Washington prevents vertical integration into retail assets. That limitation is a significant constraint on growth since Zen’s independent cultivators cannot acquire dispensary assets to internalize retail revenues that are typically about three times wholesale receipts. Stated differently, Artizen could be generating about three times its current revenues, or about $46 to $52 million, if Zen’s existing footprint was in another state. Thus, diversification has been and remains a key strategic focus – both within Washington by expanding Zen’s offerings and exploiting compliant acquisition opportunities, and in valuable emerging cannabis markets by replicating Artizen’s proven formula for success in new U.S. and Canadian geographies.
https://www.barrons.com/articles/pervasip-announces-artizen-spin-off-01673965206?mod=md_stockoverview_news
$GMER news! #Roblox #Minecraft
https://finance.yahoo.com/news/good-gaming-inc-signs-development-133000262.html
$PVSP Positioning for Expansion
“Spinning out Artizen will allow us to properly capitalize the business to take advantage of multiple expansion opportunities to build on our existing foundation,” said German Burtscher, Chairman and Chief Executive Officer of Pervasip and Artizen.
https://seekingalpha.com/pr/19084459-pervasip-announces-artizen-spin-off
$PVSP Pervasip previously announced its identification of a series of exciting expansion opportunities, including potential acquisitions involving licensed wholesale and retail operations that would offer Artizen the potential to establish itself as a vertically integrated multi-state operator (“MSO”).
https://www.benzinga.com/markets/cannabis/23/01/30465565/pervasip-announces-artizen-spin-off?utm_campaign=partner_feed&utm_source=MarketWatch&utm_medium=partner_feed&utm_content=site&mod=mw_quote_news
$PVSP While the local Washington market presents compelling opportunities for the acquisition and roll-up of wholesale flower, concentrate, and other related production assets by Zen’s independent cultivators, the regulatory environment in Washington prevents vertical integration into retail assets. That limitation is a significant constraint on growth since Zen’s independent cultivators cannot acquire dispensary assets to internalize retail revenues that are typically about three times wholesale receipts. Stated differently, Artizen could be generating about three times its current revenues, or about $46 to $52 million, if Zen’s existing footprint was in another state. Thus, diversification has been and remains a key strategic focus – both within Washington by expanding Zen’s offerings and exploiting compliant acquisition opportunities, and in valuable emerging cannabis markets by replicating Artizen’s proven formula for success in new U.S. and Canadian geographies.
https://www.barrons.com/articles/pervasip-announces-artizen-spin-off-01673965206?mod=md_stockoverview_news
$PVSP PERVASIP is in the process of looking for other opportunities to create value.
$PVSP While the local Washington market presents compelling opportunities for the acquisition and roll-up of wholesale flower, concentrate, and other related production assets by Zen’s independent cultivators, the regulatory environment in Washington prevents vertical integration into retail assets. That limitation is a significant constraint on growth since Zen’s independent cultivators cannot acquire dispensary assets to internalize retail revenues that are typically about three times wholesale receipts. Stated differently, Artizen could be generating about three times its current revenues, or about $46 to $52 million, if Zen’s existing footprint was in another state. Thus, diversification has been and remains a key strategic focus – both within Washington by expanding Zen’s offerings and exploiting compliant acquisition opportunities, and in valuable emerging cannabis markets by replicating Artizen’s proven formula for success in new U.S. and Canadian geographies.
https://www.barrons.com/articles/pervasip-announces-artizen-spin-off-01673965206?mod=md_stockoverview_news
$CYBN Cybin Announces Approval of First-in-Human Dosing of its Proprietary DMT Molecule CYB004. This is the first trial ever evaluating deuterated DMT in humans. https://ir.cybin.com/investors/news/news-details/2023/Cybin-Announces-Approval-of-First-in-Human-Dosing-of-its-Proprietary-DMT-Molecule-CYB004/default.aspx
$PVSP While nobody knows, if you do basic math from all of the publicly available data, current enterprise value of Pervasip (=all Artizen) comes in at around $40 million on a fully diluted basis without any forward-looking value attached;
That is CURRENT value; when the company announces its various licensing and acquisition opportunities, the stock will only go up from there!
$PVSP The company WILL announce various opportunities.
$PVSP While nobody knows, if you do basic math from all of the publicly available data, current enterprise value of Pervasip (=all Artizen) comes in at around $40 million on a fully diluted basis without any forward-looking value attached;
That is CURRENT value; when the company announces its various licensing and acquisition opportunities, the stock will only go up from there!
$PVSP You must be a Pervasip shareholder of record at the Record Date to take advantage of this double; buying a PVSP share the day after will not transfer to Artizen Corp
$PVSP While the local Washington market presents compelling opportunities for the acquisition and roll-up of wholesale flower, concentrate, and other related production assets by Zen’s independent cultivators, the regulatory environment in Washington prevents vertical integration into retail assets. That limitation is a significant constraint on growth since Zen’s independent cultivators cannot acquire dispensary assets to internalize retail revenues that are typically about three times wholesale receipts. Stated differently, Artizen could be generating about three times its current revenues, or about $46 to $52 million, if Zen’s existing footprint was in another state. Thus, diversification has been and remains a key strategic focus – both within Washington by expanding Zen’s offerings and exploiting compliant acquisition opportunities, and in valuable emerging cannabis markets by replicating Artizen’s proven formula for success in new U.S. and Canadian geographies.
https://www.barrons.com/articles/pervasip-announces-artizen-spin-off-01673965206?mod=md_stockoverview_news
$PVSP While nobody knows, if you do basic math from all of the publicly available data, current enterprise value of Pervasip (=all Artizen) comes in at around $40 million on a fully diluted basis without any forward-looking value attached;
That is CURRENT value; when the company announces its various licensing and acquisition opportunities, the stock will only go up from there!
What information is David Dreman & Goldman Sachs using to BUY millions of sub-Penny Stock
What news is Goldman Sachs, Blackrock, David Dreman, Putnam Investments using to BUY millions of Novation $NOVC shares? $NOVC Board triggers SEC Rule 15c2-11 which STOPs both public SEC Filings & Retail Bid/Ask but still allows expert investors aka hedge funds to Trade $NOVC Common Shares off no retail information!
Here is why I believe powerful whale-size investors, many related to $NOVC Board or controlling investors, are buying a sub-penny stock $NOVC off non-retail information courtesy of SEC https://www.marketscreener.com/quote/stock/NOVATION-COMPANIES-INC-120787360/company/
I have confirmed my thesis with both Saxon Capital $SAX ex-CEO Michael Sawyer & Jason Stewart the MREIT Director at www.jonestrading.com (ranked by TipRanks) formerly MREIT Research Director at FBR Friedman, Billings and Ramsey now EJF Capital www.ejfcap.com that investors that control $NOVC Board, $NOVC only Sr Debt to exit Ch 11 and 116M Common Shares Outstanding will not waste Novation Companies Inc. $NOVC $730M NOLs or Rights CCR defined by Section 5.04 of Service Rights Transfer Agreement, SRTA see Exhibit 2.1 of 10Q filed for Q3 2007. $NOVC Board restructured Dynex Capital $DX NYSE tax-exempt MREIT with Fortress. Now Fortress/EJF Capital/Mass Mutual & sub-Barings/Jefferies & White Mountains Capital $WTM are these investors.
Mr. Sawyer and Mr. Stewart both know these investors above and agree they are some of the greatest MREIT Market Makers of all time, specifically Fortress/EJF Capital. Wesley Edens x Blackrock, Lehman Bros/Peter Briger x Goldman Sachs Sr Partner, Co-CEOs of Fortress and Neal Wilson Manny Friedman Co-CEOs of EJF Capital formerly FBR. I shared my thesis regarding what I believe to be the true restructuring of $NOVC balance sheet and capital table. They separately agreed with the concept that $NOVC can break into 2 tax-free companies by spin-out their prior tax-exempt MREIT Novastar Financial Inc. NYSE $NFI which holds CCR cleanup call rights, that can be monetized into MREIT Dividend. The SRTA is P&S between $NOVC & $SAX for sale of MSR mortgage servicing rights, which allowed only $NOVC to retain these CCR rights that control the future use of billions in rich/seasoned collateral assets ideal to be leveraged/securitized into a tax-exempt MREIT dividend & external management fee EMF for Fortress.
Fortress cashed every year over $150M EMF at $RITM aka $NRZ until months ago when Fortress triggered a $400M termination fee. $NOVC Board and Boulay Group a top 100 CPA firm per #AICPA, paid well into 6 figures to audit/certify $NOVC 10Ks fail to disclose this in SEC filings. Fortress/EJF Capital are the 2 top MREIT Market Makers and their ownership of 100% of NOVC only Sr Debt & 27% of all $NOVC common shares are hidden behind CDOs Taberna I & II/Kodiak CDO I which they paid almost nothing to own via CDO Service Rights.
Fortress led the restructuring of Newcastle Investment Corp $NCT now traded Drive Shack $DS which retained all of the $160M NOLs as the 3 MREITs they spun out are already tax-exempt per IRC. Newcastle Investment Corp’s previous symbol $NCT became Drive Shack $DS and 3 tax-exempt MREITs were spin-out including $RITM x $NRZ, $SNR New Senior sold for $2.3B & $GCI formerly New Media X $NEWM. If they copy this restructuring blueprint at $NOVC they make BILLIONS and create an annual cash flow of hundreds of millions in dividends and EMF every year out of a sub-penny stock, not filing SEC documents or providing a retail bid/ask the courtesy of SEC Rule 15c2-11.
Evidence shows $NOVC Board of Directors; Barry Igdaloff & Howard Amster both made a mint restructuring Dynex Capital NYSE $DX with Fortress assistance. Both DX and SAX were MREIT spun out of the same public company based in Glen Allen, VA. Manny Friedman, Neal Wilson, Co-CEOs at EJF Capital were the book runners for both SAX and DX. Board has been working closely with investors Chuck Gillman/Jeff Eberwein, Fortress co CEOs Wesley Edens, Peter Briger, EJF Capital Co-CEOs Manny Friedman, Neal Wilson, Barings and Mass Mutual William Bill Wallis, x Barings CEO/Chief Investment Officer of MassMutual Thomas Finke, ex CEO/COB of Dynex Capital NYSE $DX, ex Board Member at IMH and major shareholder of $NOVC, Thomas Akin, President of Jefferies Brian Friedman, CEO of Jefferies Rich Handler, and Frank Bazos of White Mountains Capital. This is the thesis why related experienced HF investors own almost all $NOVC common, all $NOVC only Sr Debt to exit Ch 11 and control the Board of Directors. This is the thesis explaining why whale-size investors many related to $NOVC controlling investors are BUYING millions of $NOVC common at sub-penny prices https://www.marketscreener.com/quote/stock/NOVATION-COMPANIES-INC-120787360/company/
$EDXC - Endexx Corporation announces its record revenue, midway through its first fiscal quarter of 2023 and has surpassed its best yearly revenue figure by more than five hundred percent.
https://finance.yahoo.com/news/endexx-surpasses-record-annual-revenues-130000077.html
$PVSP For all cannabis connoisseurs all that needs to be said about that brand is “IYKYK” (bestselling small batch top shelf brand). Several similar arrangements will be announced soon, following through on one of the other major initiatives outlined in the January 2022 Shareholder letter.
While the cannabis market on the west coast is still challenged by its post Covid dip, massive oversupply, and egregious tax and state by state rules, brands like ArtizenTM, well-oiled distribution, top notch management teams and healthy, transparent financial structures, will be the ultimate winners in this space.
$PVSP Our focus is on developing and investing in companies and technologies in high value emerging markets, specifically Cannabis and Medical Fungi. We look for investments in operators who will become the foundational base for growth in each segment and related technologies and research assets that can support near term and future expansion.
https://www.pervasip.net/about
$MASN provides update on Aether Diamonds https://www.newmediawire.com/news/maison-luxe-provides-update-for-investment-holding-aether-diamonds-the-world-s-only-carbon-negative-diamond-producer-7060078
$PVSP the mature markets provide relevant insights into future sales distribution across key categories with flower and pre-rolls still leading at 59%, followed by concentrates (dabs/vape) at 29% and finally edibles and beverages at a combined 9%
Artizen brands will materially expand their flower market share and enter the concentrates and edibles market with a goal of occupying top 10% market share positions in each vertical.
$PVSP “Q3 2022 shows material signs of improvement over Q2 2022 reflecting our ongoing operational focus. As stated before, we continue to pursue our strategic goals even during these difficult market conditions as evidenced by our recent agreements on terms for the acquisition of the Emerald City Cultivation and Dabco brands. Our operational and financial focus on rationalizing our business, shedding underperforming assets, and increasing production yields by our independent cultivators continues to proceed and have allowed us to continue with additional market share capture. Investing in Cannabis is not for the faint of heart and we believe we are building a solid foundation for years to come which takes time, patience, and relentless focus on fundamentals. In an industry that does not have access to traditional financing, our options are limited and expensive,” said German Burtscher, Pervasip’s CEO. “We slowed the rollout of our new concentrate brands which we licensed for Q3 deployment and instead focused on an outright acquisition as the opportunity became available. That resulted in not meeting the forecasted revenue from the new product lineup for Q3. We are also pursuing a conservative approach to working within the complicated tax environment our industry is confronted with. Ongoing work in support of the audit process and a recent court ruling that impacts the cannabis industry caused us to change our estimates for tax liability dating back to prior periods 2017 – 2020, which we booked in Q3.”
https://seekingalpha.com/pr/18980304-pervasip-announces-3rd-quarter-financials
$PVSP SEATTLE, Oct. 18, 2022 (GLOBE NEWSWIRE) -- Pervasip Corp. (OTCPK: PVSP) (“Pervasip” or the “Company”), a developer of companies and technologies in high value emerging markets, today announced the filing of its unaudited financial statements for its 3rd Quarter ended August 31, 2022.
https://www.nasdaq.com/press-release/pervasip-announces-3rd-quarter-financials-2022-10-18
$PVSP “Q3 2022 shows material signs of improvement over Q2 2022 reflecting our ongoing operational focus. As stated before, we continue to pursue our strategic goals even during these difficult market conditions as evidenced by our recent agreements on terms for the acquisition of the Emerald City Cultivation and Dabco brands. Our operational and financial focus on rationalizing our business, shedding underperforming assets, and increasing production yields by our independent cultivators continues to proceed and have allowed us to continue with additional market share capture. Investing in Cannabis is not for the faint of heart and we believe we are building a solid foundation for years to come which takes time, patience, and relentless focus on fundamentals. In an industry that does not have access to traditional financing, our options are limited and expensive,” said German Burtscher, Pervasip’s CEO. “We slowed the rollout of our new concentrate brands which we licensed for Q3 deployment and instead focused on an outright acquisition as the opportunity became available. That resulted in not meeting the forecasted revenue from the new product lineup for Q3. We are also pursuing a conservative approach to working within the complicated tax environment our industry is confronted with. Ongoing work in support of the audit process and a recent court ruling that impacts the cannabis industry caused us to change our estimates for tax liability dating back to prior periods 2017 – 2020, which we booked in Q3.”
https://seekingalpha.com/pr/18980304-pervasip-announces-3rd-quarter-financials
$PVSP ZAM provides consulting, leasing, intellectual property licensing and other long-term arrangements to cannabis operators, including management of the Artizen™ brand assets
https://www.pervasip.net/zen-asset-management-zam
$PVSP Our focus is on developing and investing in companies and technologies in high value emerging markets, specifically Cannabis and Medical Fungi. We look for investments in operators who will become the foundational base for growth in each segment and related technologies and research assets that can support near term and future expansion.
https://www.pervasip.net/about
$PVSP Pervasip Announces 3rd Quarter Financials
https://finance.yahoo.com/news/pervasip-announces-3rd-quarter-financials-130000191.html
$PVSP We also invested in a small Korea based research entity, KRTL, to establish an early foothold in the rapidly expanding world of medical fungi, with a specific focus on Psilocybin. It is an entry to a large database of related research, various research entities actively involved in related development projects and provides Pervasip with a perfect perch to look at various fungi opportunities across the globe.
$PVSP SEATTLE, Oct. 18, 2022 (GLOBE NEWSWIRE) -- Pervasip Corp. (OTCPK: PVSP) (“Pervasip” or the “Company”), a developer of companies and technologies in high value emerging markets, today announced the filing of its unaudited financial statements for its 3rd Quarter ended August 31, 2022.
https://www.nasdaq.com/press-release/pervasip-announces-3rd-quarter-financials-2022-10-18
$PVSP in beautiful Port Townsend, on the northern end of the Olympic Peninsula, this gorgeous light deprivation greenhouse garden is producing beautiful flower and is home to some of the more exotic genetics in the Artizen brand. At 39,000 square feet it is the second largest of all of the gardens growing Artizen branded flower.
$PVSP SEATTLE, Oct. 18, 2022 (GLOBE NEWSWIRE) -- Pervasip Corp. (OTCPK: PVSP) (“Pervasip” or the “Company”), a developer of companies and technologies in high value emerging markets, today announced the filing of its unaudited financial statements for its 3rd Quarter ended August 31, 2022.
https://www.nasdaq.com/press-release/pervasip-announces-3rd-quarter-financials-2022-10-18
$GOGY trading just over its 10-day average volume as we head into the last 2 hours of the day. Green for the week!
$GOGY trader's cheat sheet https://www.barchart.com/stocks/quotes/GOGY/cheat-sheet
$SFLm - SFLMaven recently announced the launch of its second line of NFTs in the Decentraland Metaverse. It is also working on developing a new novel technology that displays the value of an NFT along with the avatar in any Metaverse environment. SLFMaven started as a vintage jewelry store on eBay that still does over $1 million in sales each month. SFLMaven’s next line of NFTs is believed to be launching in Decentraland in the new year.
https://pubcoinsight.com/moncler-is-the-latest-fashion-brand-to-join-the-metaverse
$LUDG - Ludwig Inc. is forging partnerships like one with Emerson Urology Associates where its upcoming Ludwig mRNA Inflammatory Index will be used when it is ready. It is also using the data from this index to create early indications and triggers for the early detection of diseases like cancer, strokes, and heart disease. These advancements from Ludwig are tremendous and could lead to a future where life expectancy is lengthened and difficult and traumatic battles against diseases are reduced significantly.
https://pubcoinsight.com/medical-technology-stocks-9/
$HLRTF Hillcrest Inverter Technology Applications
E-mobility: The first application of our flagship inverter technology is focused on vehicle electrification and other e-mobility applications. The 250kW 800V SiC EV inverter commercial prototype will be delivered in 2022.
Grid-connected renewable power: The second high-potential application of our flagship inverter? technology is expected to be grid-connected power generation. A 250kW 800V grid inverter is already under development and is expected in 2023.
Enhanced EV powertrain: The Hillcrest inverter? technology is also being applied to an enhanced electric powertrain solution. The Hillcrest inverter-enabled enhanced powertrain solution is already under development and is expected in 2023.
High-power inverter applications: The Hillcrest inverter? technology can also be applied to medium/high power industrial applications such as utility-scale renewable energy generation, rail and cargo. A high-power inverter application is currently in early stages of development.
Followers
|
257
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
17497
|
Created
|
01/30/03
|
Type
|
Free
|
Moderator Pennybuster | |||
Assistants |
For Charts Go To http://www.stockcharts.com
Penny Stock Investing
The Nature of Penny Stocks
For anyone new to investing in penny stocks, you should first be made aware of the differences between these micro-cap stocks and the more conventional blue-chip and mid-cap investments. Unlike buying shares in a large, stable company like Ford or IBM, you are dealing with speculative investments.
Penny stocks literally trade for pennies per share, or for as much as a couple of dollars. The beauty of penny stocks, of course, is that sometimes they 'grow up' and become mid-cap stocks, multiplying in value hundreds of times over and making many people very wealthy.
With penny stocks, also called micro-caps or juniors, you will see much greater price volatility, and thus greater and quicker gains and losses in asset values. It is precisely this volatility which draws investors to the junior markets, as one good pick could make you hundreds of times what you could ever make on the larger markets.
Of course, there is more risk than buying bonds, blue chips or defensive stocks - but this added risk is tempered with the possibility of making the big gains.
Most penny stocks, but not all, are resource or technology companies who initially sold shares in an effort to raise money for exploration or product development programs. Many of the companies have large debt loads and are not necessarily making more money than they are losing.
However, it is the potential of a major, or even minor success in their quest that often incites dramatic price climbs, and this is where their value lies.
Profit Potential
Modern Strategies Inc. has been in the business of researching penny stocks for many years, and has become effective at uncovering the best small cap investment opportunities and the most rewarding profit situations in the penny stock markets.
There are several ways to profit from penny stock investments. Modern Strategies Inc. has uncovered the most highly rewarding investment situations.
Promotional Stocks - These issues may or may not have much actual value. Promoters generate interest in these type of stocks in an attempt to drive share prices higher. The promoters own great amounts of shares and so they make more money the higher the share price travels. Eventually, they sell their holdings into the promotion and generate great personal profit. Then they move on to the next project, leaving the original stock and all its investors behind. Without the work of the promoter, the promotional issue soon comes crashing down.
These are the type of stock investor hear horror stories about, because many people often lose a good deal of money when they are naive about promotional ploys. However, getting in on a promotional stock early in its life cycle, and keeping an eye on the actions of the promoter can be very, very rewarding. It's like having a full time stock promoter doing everything in his power to get the share prices of the stocks you own to go through the roof, and investors who get in early can go along for the ride!
Technical Precursors - Often technical analysis can reveal patterns in the trading cycles of penny stocks. Sometimes these patterns illustrate excellent buying opportunities, where the underlying stock has a high probability of moving up strongly, and only a low probability of declining in value.
In addition, there are sometimes situations where several positive technical indicators combine at once to reveal that an issue is very likely to increase strongly in price over a short time frame, indicating that the particular issue is has excellent investment potential.
Fundamental Strength - Fundamentals involve such criteria as earnings, debt load, assets, and many others. It was long thought that earnings were the major driving force behind share prices, but Modern Strategies Inc. has since disproved this theory as it applies to penny stock companies. Instead, uncovering the best medium to long term investment opportunities must be done through exhaustive analysis of company financial statements. Investors should get involved with the companies that are making the most money, have the most effective management, and have improving trends in all factors of their operations. As well, industry comparisons and the examination of key financial ratios present clues as to which companies are destined for higher share prices.
Proper fundamental analysis of penny stock companies will generally reveal that there are about 2 or 3 superior investment opportunities out of every 100 companies examined. These 2 or 3 excellent corporations often represent better investments than 90% of stocks on the large-cap markets like the NYSE.
Undervalued Situations - Sometimes companies see their share price slide dramatically. There are occasions where this decrease in price has very little to do with the underlying fundamentals, and more to do with factors such as overall market weakness, interest rate increases, or others.
Opportunity exists in such situations because the shares are often 'unfairly valued' and a return to more realistic prices is inevitable. There are often cases where companies have more cash on hand per share than their share price, or have price to earnings ratios as low as 5.0. Although there is much more to uncovering the best undervalued situations, this is the basis behind the concept.
Minimized Downside - Often the combination of technical analysis and undervalued situations can reveal penny stock companies that have tremendous upside potential, and have a very low probability of declining in value to any significant degree.
These type of investments are excellent choices for penny stock investors that are less risk adverse.
Special Notes About Penny Stock Companies
Penny stock companies change their names more commonly than other publicly traded companies, and are also subject to more stock-swaps and consolidations. In any of these events, your shares in your account will be automatically replaced with the appropriate stock by your broker and notice will be delivered to you.
For example, if you owned 5000 shares of EXO and for every 5 shares you were to receive 2 shares of LOR, you would find your account holdings re-adjusted to reflect 2000 LOR which can be traded as normal. You will no longer have the 5000 EXO.
On rare occasions, a penny stock company can become delisted. This means that the shares will no longer trade on the exchange, and if the company does not get listed on another exchange or re-instated at a future date, you may be subject to a loss of capital equal to 100% of the total investment. However, this is a very rare occurrence, and there are simple ways to protect yourself against it which are periodically discussed in Modern Strategies Inc. publications. Delisting generally becomes a greater concern for investors who intend to use a long-term (several years) buy and hold strategy with penny stocks.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |